Field Trip Health Ltd. (FTRP) Stock
Field Trip Health Ltd., established in 2008 and based in Toronto, Canada, specializes in developing and delivering psychedelic-based therapeutic treatments across North America. The company operates dedicated Field Trip Health Centres providing these therapies, offers digital support through Field Trip Digital applications, and conducts pharmaceutical research via its Field Trip Discovery division, which focuses on creating next-generation psychedelic compounds.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Field Trip Health Ltd.
Field Trip Health Ltd., established in 2008 and based in Toronto, Canada, specializes in developing and delivering psychedelic-based therapeutic treatments across North America. The company operates dedicated Field Trip Health Centres providing these therapies, offers digital support through Field Trip Digital applications, and conducts pharmaceutical research via its Field Trip Discovery division, which focuses on creating next-generation psychedelic compounds. Additionally, Field Trip Health Ltd. provides ketamine-assisted therapy to help individuals manage depression, anxiety, addiction, and other related conditions.
Field Trip Health Ltd. is headquartered in CA.
Field Trip Health Ltd. (FTRP) stock trades at $0.84 with a market capitalization of $9.81M. The stock is valued at a price-to-earnings (P/E) ratio of -0.14, price-to-book of 0.12, price-to-sales of 2.84.
On profitability, Field Trip Health Ltd. generates a return on equity (ROE) of -61.81%, return on capital employed of -57.20%, an operating margin of -1080.00%, a net profit margin of -1120.00%.
Official website: www.fieldtriphealth.com